Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan · Delayed Price · Currency is JPY 1,519.00
-6.00 (-0.39%)
Oct 23, 2025, 9:03 AM JST
Santen Pharmaceutical Revenue
Santen Pharmaceutical had revenue of 68.74B JPY in the quarter ending June 30, 2025, a decrease of -8.07%. This brings the company's revenue in the last twelve months to 293.97B, down -3.41% year-over-year. In the fiscal year ending March 31, 2025, Santen Pharmaceutical had annual revenue of 300.00B, down -0.65%.
Revenue (ttm)
293.97B
Revenue Growth
-3.41%
P/S Ratio
1.68
Revenue / Employee
76.38M
Employees
3,849
Market Cap
492.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 300.00B | -1.96B | -0.65% |
| Mar 31, 2024 | 301.97B | 22.93B | 8.22% |
| Mar 31, 2023 | 279.04B | 12.78B | 4.80% |
| Mar 31, 2022 | 266.26B | 16.65B | 6.67% |
| Mar 31, 2021 | 249.61B | 8.05B | 3.33% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.20T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |
Santen Pharmaceutical News
- 5 months ago - Santen Pharmaceutical Co., Ltd. reports Q4 results - Seeking Alpha
- 3 years ago - Santen Pharmaceutical Co., Ltd. (SNPHY) Management on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha